Colorado Genetic Privacy Laws: Compliance Guide for NGS Labs Sharing Carrier Screening Results with Outside Genetic Counselors

Overview of Colorado Genetic Information Privacy Framework

For NGS laboratories that generate carrier screening results and share them with outside genetic counselors, Colorado’s framework combines federal HIPAA rules with state consumer privacy and sector-specific statutes. The throughline is Genetic Data Confidentiality, with heightened expectations for handling Protected Health Information (PHI) and any genetic data processed outside HIPAA.

HIPAA governs most lab workflows involving PHI and permits necessary uses and disclosures in care delivery, while imposing privacy and security obligations across policies, workforce practices, and technology. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html?utm_source=openai))

The Colorado Privacy Act (CPA) applies to entities (including many nonprofits) that meet statutory thresholds and process personal data about Colorado residents. CPA requires Data Minimization and opt-in consent before processing sensitive data, which includes genetic or biometric data used for unique identification; however, PHI handled by HIPAA covered entities and business associates is exempt. ([coag.gov](https://coag.gov/resources/colorado-privacy-act/?utm_source=openai))

Colorado also codifies genetic privacy in specific contexts. For example, insurance statutes restrict use and disclosure of information derived from genetic testing, and certain parentage-testing records are confidential under public health laws. While these are not lab-wide rules, they underscore the state’s privacy posture. ([colorado.public.law](https://colorado.public.law/statutes/crs_10-3-1104.7?utm_source=openai))

Finally, SB26-162 (2026) proposed a targeted Electronic Health Record Delay for certain cancer-related pathology, radiology, or genetic results, but the bill was postponed indefinitely and did not become law. Its trajectory signals policy attention to timing of sensitive result release. ([leg.colorado.gov](https://leg.colorado.gov/bills/SB26-162))

Consent Requirements for Genetic Data Sharing

Sharing carrier screening results with an outside genetic counselor who is involved in the patient’s treatment is generally permitted under HIPAA without a patient authorization, and the “minimum necessary” standard does not apply to treatment disclosures. Ensure the counselor’s role is treatment-related and document that relationship. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html?utm_source=openai))

When a disclosure is not for treatment, payment, or health care operations, obtain a valid HIPAA authorization—your Third-Party Authorization—before releasing identifiable results. This includes disclosures to non-clinical third parties or for marketing purposes. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html?utm_source=openai))

If part of your operations falls outside HIPAA (for example, any direct-to-consumer workflow), the CPA requires explicit Informed Consent before processing sensitive data such as genetic information and clear purpose specification for any third-party sharing. Keep consent language plain, granular, and revocable. ([coag.gov](https://coag.gov/resources/colorado-privacy-act/?utm_source=openai))

Disclosure Limitations and Third-Party Access Controls

Segment disclosures based on purpose. For treatment-related sharing with an independent counselor, disclose what is necessary for care. For non-treatment purposes, require a signed authorization and verify the requestor’s identity and authority. Always log disclosures of genetic PHI. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html?utm_source=openai))

Contractual controls matter. If a counselor or platform performs services for your lab (e.g., triaging results, scheduling post-test counseling), execute a Business Associate Agreement detailing permitted and required uses, safeguards, and breach duties. If the party is a CPA “processor,” include data processing terms mirroring CPA obligations. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/business-associates/index.html?utm_source=openai))

Apply Data Minimization and need-to-know access policies across your systems, especially when routing results through portals, SFTP, or APIs. Limit fields to what the counselor needs, and set default denylists for downstream recipients that are not part of care. ([coag.gov](https://coag.gov/resources/colorado-privacy-act/?utm_source=openai))

Data Security Standards for Genetic Information

Implement the HIPAA Security Rule’s administrative, physical, and technical safeguards for ePHI. Start with a documented risk analysis, then tailor controls to protect the confidentiality, integrity, and availability of genetic data throughout sequencing, interpretation, reporting, and exchange. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/security/laws-regulations/index.html?utm_source=openai))

Adopt strong Encryption Protocols for data at rest and in transit; while HIPAA treats encryption as an addressable (not strictly mandatory) implementation specification, it is a de facto baseline for modern lab environments handling sensitive results. Use contemporary algorithms and manage keys securely. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/faq/is-the-use-of-encryption-mandatory-in-the-security-rule/index.html?utm_source=openai))

Operationalize least privilege, unique user IDs, MFA, network segmentation, and continuous monitoring. Review access logs and system activity, and reassess risks whenever workflows or systems change to keep safeguards aligned with real-world threats. ([law.cornell.edu](https://www.law.cornell.edu/cfr/text/45/164.308?utm_source=openai))

HIPAA Compliance for Genetic Counselors

Many outside genetic counselors are HIPAA covered entities; they independently owe HIPAA duties when receiving carrier screening results for patient care. If a counselor acts on your behalf (rather than as an independent provider), they are a business associate and must operate under a BAA that binds their uses and disclosures of PHI. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/covered-entities/index.html?utm_source=openai))

Confirm the counselor’s status, exchange only the information necessary for the intended purpose, and align both parties’ privacy notices and security safeguards. Where a counselor is a business associate, their statutory compliance duties and penalties apply directly. ([uscode.house.gov](https://uscode.house.gov/view.xhtml?req=%28title%3A42+section%3A17934+edition%3Aprelim%29&utm_source=openai))

Colorado Privacy Act and Its Impact

For non-HIPAA processing, the CPA imposes opt-in consent for sensitive personal data, explicit purpose limitation, Data Minimization, and consumer rights (access, correction, deletion, and opt-out of sales/targeted ads). The law applies to entities meeting scope thresholds and includes many nonprofits. ([coag.gov](https://coag.gov/resources/colorado-privacy-act/?utm_source=openai))

PHI processed by HIPAA covered entities and business associates is exempt from the CPA, but mixed operations are common. If your lab runs HIPAA and non-HIPAA lines of business, segregate systems, policies, and notices so each dataset is governed correctly. ([codes.findlaw.com](https://codes.findlaw.com/co/title-6-consumer-and-commercial-affairs/co-rev-st-sect-6-1-1304/?utm_source=openai))

Compliance with SB26-162 for Sensitive Genetic Results

As of September 18, 2026, SB26-162 was postponed indefinitely and is not in effect. If a similar measure is enacted in the future, it would require a 3‑business‑day Electronic Health Record Delay for certain cancer-related pathology, radiology, or genetic results, with provider-authorized early release and EHR custodians responsible for implementation. The reengrossed bill also stated that compliance would not constitute information blocking. ([leg.colorado.gov](https://leg.colorado.gov/bill_files/117271/download))

If you choose to align proactively, configure your EHR/LIS to: classify affected tests; hold results for three business days by default; allow documented provider overrides; and surface clear patient messaging about timing. When state law requires a delay, ONC guidance indicates a limited, necessary delay to comply with that law is unlikely to be considered information blocking. ([healthit.gov](https://healthit.gov/faq/when-would-delay-fulfilling-request-access-exchange-or-use-ehi-be-considered-interference-under?utm_source=openai))

Bottom line: anchor result-sharing in HIPAA, apply CPA duties to any non-HIPAA processing, contract and log third-party access rigorously, and harden security around encryption and least privilege. If sensitive-result delay legislation advances, you’ll be ready to implement without disrupting counselor-enabled care. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/security/laws-regulations/index.html?utm_source=openai))

FAQs

What are the consent requirements for sharing genetic results in Colorado?

For treatment, HIPAA permits sharing carrier screening results with an outside genetic counselor without a patient authorization, and the “minimum necessary” rule does not apply to treatment disclosures. For non-treatment purposes, obtain a HIPAA authorization. If any part of your activity falls outside HIPAA, the Colorado Privacy Act requires opt-in consent to process sensitive genetic data and strong purpose limitation. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html?utm_source=openai))

How does SB26-162 affect genetic test result disclosures?

SB26-162 did not become law; it was postponed indefinitely on May 8, 2026. Had it passed, it would have required a 3‑business‑day delay before releasing specified cancer-related pathology, radiology, or genetic results to a patient portal/EHR, with provider-authorized early release and implementation by the EHR custodian. ([leg.colorado.gov](https://leg.colorado.gov/bills/SB26-162))

What security measures must NGS labs implement for genetic data?

Implement HIPAA Security Rule safeguards: perform a risk analysis; enforce administrative, physical, and technical controls; and use strong encryption in transit and at rest (encryption is an addressable but expected safeguard). Maintain audit logs, least-privilege access, and continuous monitoring to protect genetic ePHI across sequencing, interpretation, reporting, and exchange. ([hhs.gov](https://www.hhs.gov/hipaa/for-professionals/security/laws-regulations/index.html?utm_source=openai))